A variety of human diseases, including neurodegenerative disorders, ischemic heart disease, diabetes, and cancer have been reported to be associated with mitochondrial dysfunction. Because of this, mitochondrial therapy is expected to be useful and productive in the treatment of such diseases. We previously reported on the development of a MITOPorter, a liposome-based nanocarrier that permits macromolecular cargos to be delivered into mitochondria via membrane fusion. Intracellular observations using the green ‰uorescence protein as a model macromolecule provided conˆr-mation that a macromolecule could be delivered to mitochondria in living cells by the MITO-Porter. Here, we present our currentˆndings on the development of mitochondrial medicine and mitochondrial gene therapy based on our mitochondrial drug delivery system (DDS). In this review, we propose``mitochondrial DDS'' as a theme for``DDS research for innovative drug development'' and discuss the contribution of mitochondrial DDS to innovative drug development.
Naked pDNA was intravenously injected into the dorsalis pedis vein via hydrodynamic injection. It is generally thought that the pDNA is internalized into cells via hydrodynamic force, resulting in the localization of pDNA in mitochondria. Thisˆgure is reproduced in part with permission from Elsevier. A, Evaluation of exogenous pDNA-levels in mitochondria-enriched fraction following hydrodynamic injection. Naked pDNA was injected into the distal of the limb by the hydrodynamic injection of naked pDNA, and the mitochondria-enriched fraction was isolated from the crural muscles at 24 h postinjection. PCR assays were performed in order to detect endogenous mtDNA and exogenous pDNA, respectively. Lane 1, naked pDNA administration; lane 2, saline administration. B, EŠects of injection volume (left graph) and the dose of pDNA (right graph) on mitochondrial delivery by the hydrodynamic injection of pDNA. At 24 h after hydrodynamic injection under various condition, the crural muscles were harvested, and the pDNA in mitochondria-enriched fraction was then measured using q-PCR. Bars indicate means±S.E. 
